Autres langues Morepen Laboratories Limited NSE India S.E.

Actions

MOREPENLAB

INE083A01026

Temps Différé NSE India S.E. Autres places de cotation 09:12:20 18/05/2024			Varia. 5j.	Varia. 1 janv.
47,9 ^INR	+2,24%		+3,79%	-1,34%

30/03	Morepen Laboratories Limited annonce la démission de Lalit Kumar Baregama, Directeur de la croissance	CI
01/03	Morepen Laboratories Limited annonce la promotion d'Amita Sharma au poste de Chief Operating Officer -API	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Morepen Laboratories : Change in the date of appointment of Mr. Nishant Jayesh Doshi, V P - Corp. Fin. & Investor Relations ('SMP') Change in Senior Management Personnel - Mr. Rajesh Kumar Singh	02/05
Morepen Laboratories Limited Announces Resignation of Lalit Kumar Baregama, Chief Growth Officer	30/03
Morepen Laboratories : Dr. Morepen Partners with OptiBiotix to Deliver Safe, ScienceBacked Weight Management Solution to India	19/03
Morepen Laboratories Limited Announces the Promotion of Amita Sharma to Chief Operating Officer -API	01/03
Morepen Laboratories Limited Approves the Appointment of Vikas Sharma, Talent Acquisition & HRBP, Functional Head	31/01
Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	31/01
Morepen Laboratories Limited Announces Resignation of Rolli Saxena, General Manager - HR, Being A Functional Head and Senior Management Personnel	01/12
Morepen Laboratories Limited Appoints Shantanu Tuli as President -Strategy and Brand Identity, Effective from December 1, 2023	30/11
Morepen Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	02/11
Morepen Laboratories to Transfer Formulation Distribution and Marketing Business to Subsidiary	15/08/23
Morepen Laboratories : Investors presentation - Q1' FY 2023-24	08/08/23
Morepen Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	05/08/23
Morepen Laboratories' Net Profit Drops in Fiscal Q4	16/05/23
Morepen Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	16/05/23
US FDA Clears Morepen Laboratories' Baddi, India	27/03/23
Morepen Laboratories Forms Wholly-Owned Subsidiary	20/03/23
Morepen Laboratories Limited Announces Incorporation of Wholly Owned Subsidiary	17/03/23
Morepen Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/02/23
Morepen Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10/11/22
Morepen Laboratories : Transcript of EGM dated March 05, 2022 Audited Financial results for the quarter and financial year ended March 31, 2022 Unaudited financial results for the quarter and nine months ended December 31, 2021 Unaudited Financial results for the quarter and half year ended September 30, 2021 Unaudited Financial results for the quarter ended June 30, 2021	08/09/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Morepen Laboratories Limited NSE India S.E.

Actions

MOREPENLAB

INE083A01026

Autres langues

Filtres